secwatch.observer — SEC 8-K summary
======================================

Issuer:     NantHealth, Inc. (—)
CIK:        0001566469
Form:       8-K
Filed at:   2023-10-05T23:59:59+00:00
Accession:  0001566469-23-000063
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 2.04, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NantHealth receives $75M note repurchase demand from Highbridge; capital commitments from Nant Capital
--------------------------------------------------------------------------------

- Highbridge, holding $75M in convertible notes, exercised repurchase right on Sep 29, 2023; closing Oct 18, 2023.
- Company paid Highbridge cash interest on Sep 7, 2023 despite disputing entitlement; Nant Capital also requests cash interest.
- Nant Capital invested $6M and Summus $1.5M on Aug 28 under Stock Purchase Agreement; additional $2M accessible upon board approval.
- Special Committee requested Nant Capital fund $10M Additional Capital Commitment by Oct 9, 2023, required by Dec 31, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1566469/000156646923000063/0001566469-23-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1566469/000156646923000063/nh-20230929.htm
  HTML page:      https://secwatch.observer/filing/0001566469-23-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer